Sign in
CompletedNo phase

The Success of Lumbar Sympathetic Ganglion Block Using Lower Extremity Perfusion Index

Key facts

Who runs it
Jeongsoo Kim
Where
South Korea1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
40 people enrolled
Started
13 Feb 2024
Ended
30 May 2024
Type of study
Interventional
Treatments tested
  • Lumbar Sympathetic Ganglion Block
Record updated
11 July 2024

Who can take part

Age
19 years to 85 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Lower extremity pain
  • Pain for more than 3 months
  • 19 - 85 years

Who cannot take part

  • If the patient has previously undergone lumbar sympathetic ganglion removal or neurolysis
  • In the presence of vascular disorders in the lower extremities
  • If there is a systemic infection or infection at the injection site
  • If the patient has allergies to the injected medication
  • If the patient refuses to undergo the procedure
  • When there are abnormalities in blood coagulation tests
  • In the presence of anatomical deformities at the injection site
  • In other cases where the researcher deems the patient unsuitable for participation

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The patient, who is experiencing chronic pain in the lower extremities persisting for more than three months, is scheduled to undergo lumbar sympathetic ganglion block. To evaluate the technical success of the sympathetic blockade, temperature and perfusion index (PI) will be measured at one-minute intervals over a 20-minute period before and after the procedure on the treated side and the opposite side foot. Additionally, other variables related to the procedure will be assessed before the procedure, after the procedure, before discharge, and during follow-up outpatient visits or phone surveys at 1 week and 1 month after the procedure.

The group in the trial

  • Lumbar Sympathetic Ganglion Block (LSGB)Other group

    FS-guided LSGB at L3 level.

    Treatment: Lumbar Sympathetic Ganglion Block

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Success of Lumbar Sympathetic Ganglion Block Using Lower Extremity Perfusion Index: A Prospective Observational Study
Record updated
11 July 2024